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Abstract
The aim of this study was to integrate human clinical, genotype, mRNA microarray and 16 S rRNA sequence data collected
on 84 subjects with ileal Crohn’s disease, ulcerative colitis or control patients without inflammatory bowel diseases in order
to interrogate how host-microbial interactions are perturbed in inflammatory bowel diseases (IBD). Ex-vivo ileal mucosal
biopsies were collected from the disease unaffected proximal margin of the ileum resected from patients who were
undergoing initial intestinal surgery. Both RNA and DNA were extracted from the mucosal biopsy samples. Patients were
genotyped for the three major NOD2 variants (Leufs1007, R702W, and G908R) and the ATG16L1T300A variant. Whole
human genome mRNA expression profiles were generated using Agilent microarrays. Microbial composition profiles were
determined by 454 pyrosequencing of the V3–V5 hypervariable region of the bacterial 16 S rRNA gene. The results of
permutation based multivariate analysis of variance and covariance (MANCOVA) support the hypothesis that host mucosal
Paneth cell and xenobiotic metabolism genes play an important role in host microbial interactions.
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Introduction
Inflammatory bowel diseases are complex genetic disorders
resulting from the interplay of genetic and environmental factors
[1–3]. Crohn’s diseases (CD) and ulcerative colitis (UC) represent
the two major inflammatory bowel diseases (IBD) phenotypes
and are distinguished by different patterns of disease location.
The inflammation in CD patients may be located anywhere
along the gastrointestinal tract, but in the majority (80%) of CD
patients, the terminal ileum is involved. In UC, the inflammation
is confined to the colon. Because there is evidence that isolated
Crohn’s colitis are associated with genetic factors that are distinct
from ileal CD, and the overlap between genetic factors associated
with UC and isolated Crohn’s colitis, we have focused our
attention on the ileal CD subphenotype as a relatively homog-
enous category that is distinct from isolated colitis (CD or UC)
and non-IBD controls [4–6].
Single nucleotide polymorphisms in the NOD2 gene and the
ATG16L1 gene have been linked to alterations in innate host
immunity, particularly Paneth cell function and with ileal CD
phenotype [7–14]. We previously reported that increased CD3D
mRNA expression in disease affected ileum resected from 18 ileal
CD patients was associated with NOD2 genotype [15]. We also
observed alterations in mRNA gene expression in the disease
unaffected proximal margin of resected ileum from 19 ileal CD
patients compared to 9 control non-IBD patients, regardless of
NOD2 genotype [15]. The microarray dataset has recently been
further expanded to include 47 ileal CD, 27 UC and 25 non-IBD
control subjects (total=99).
Culture-independent microbiological technologies coupled
with high-throughput DNAsequencing have uncovered altera-
tions in human intestine-associated microbial compositions
(‘‘dysbiosis’’) in IBD patients compared with controls [16–25].
Ileal CD phenotype has been also associated with shifts in
intestinal and fecal microbial composition, particularly reduced
relative frequency of Faecalibacterium prausnitzii [19], [20], [23]. In
addition to disease phenotype, exploratory analyses have also
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e30044associated NOD2 genotype to intestinal associated microbial
composition [22]. We have recently completed 16 S rRNA
sequence analysis on an independent set of disease-unaffected
ileal biopsies collected of 52 ileal CD, 58 colitis and 60 control
patients without IBD undergoing initial surgical resection [24].
Of the 170 subjects with microbial composition data and 99
subjects with mRNA expression profiles, 84 subjects had paired
microarray and microbial datasets. We report here the results of
permutation based MANCOVA of these paired mRNA expres-
sion and microbial profiles in 34 ileal CD, 27 UC and 23 non-
IBD control patients.
Results
Patient Characteristics
As shown in Table 1, 35% of ileal CD patients harbored at
least one NOD2 risk allele (NOD2R) compared to 13% of
nonIBD control patients, consistent with previous studies [1–3].
Only one ileal CD patient was homozygous for the ATG16L1
nonrisk allele. The patients were predominantly Caucasian. The
median age of surgery was lower in ileal CD patients than
nonIBD control patients. Thirty percent of colitis patients had
a concomitant C. difficile infection, consistent with the increased
incidence of this infection noted previously in IBD patients [26],
[27]. Thirty to fifty percent of IBD patients and none of the non-
IBD control patients were treated with 5-aminosalicylic acid (5-
ASA), steroids, immunomodulators or an anti-TNFa agent. All of
the subjects received intravenous antibiotics within one hour of
incision [28].
Comparison of Ileal Mucosal Expression Profiles between
Ileal CD, UC and non-IBD Control Subjects
Normalization and pre-processing of the data to filter out
undetectable gene-probes resulted in a total of 26,765 gene-
probes. Because this number of variables still greatly exceeded the
sample size, we sought to further reduce the number of input
microarray variables. We reasoned that genes that were differen-
tially expressed between the three disease phenotypes were most
likely to be involved in altering host-microbial interactions. Two-
class unpaired SAM analysis was used to identify genes
differentially expressed (fold change .1.5, FDR ,0.05) between
ileal CD and Control samples, between UC and Control samples,
and between CD and UC samples [29]. The results indicate
significant differences in gene expression patterns between all three
disease phenotypes (see Table S1) [30], [31]. By taking the union
of the candidate genes identified by the three two-class compar-
isons, the dimensions of the normalized microarray data was
reduced from 26,765 to a 2,979 gene-probe set (see Fig. 1).
Hierarchical clustering of the 2,979 gene-probe set was then
carried out by using 1-correlation dissimilarities and Ward linkage
as previously described [32], [33]. The number of clusters was
chosen to be 43, based on inspection of the R2 plot (see Table S2).
Hierarchical clustering of the original 26,765 gene-probe set was
also carried out using the same algorithms to 265 clusters. This
number of clusters was again chosen based on inspection of the R2
plot. In all but four (clusters #14, 20, 31, 36) of the 43 clusters,
greater than 40% of the gene-probes were concentrated in two of
the 265 clusters obtained by clustering the original 26,765 gene-
probe set, indicating that using SAM to reduce the number of
Table 1. Distribution of NOD2 composite and ATG16L1 genotype and clinical characteristics of ileal CD, colitis and control non-IBD
patients.
Variables
Ileal CD
(n=34)
UC
(n=27)
Control
(n=23) P-value FDR
NOD2 genotype 0.11 0.15
NOD2
R (R/R + R/NR) 35% 19% 13%
NOD2
NR (NR/NR) 65% 81% 87%
ATG16L1 genotype 0.23 0.28
ATG16L1
R/R 41% 41% 43%
ATG16L1
R/NR 56% 41% 35%
ATG16L1
NR/NR 3% 18% 22%
Gender (male) 38% 59% 30% 0.095 0.14
Race (Caucasian) 94% 96% 96% 0.92 0.92
Median age (range) y 36 (21–59) 43 (17–64) 55 (32–84) ,0.001 ,0.001
Current smoker 38% 11% 22% 0.048 0.08
Positive fecal C. difficile toxin 0% 30% 0% ,0.001 ,0.001
Median BMI (range) kg/m
2 25 (16–38) 24(18–43) 28(20–38) 0.43 0.47
5-ASA 52% 70% 0% ,0.001 ,0.001
Steroids 55% 74% 0% ,0.001 ,0.001
Immunomodulators 50% 52% 0% ,0.001 ,0.001
Anti-TNFa biologics 0.003 0.006
Current (#8 weeks) 35% 41% 0%
Past (.8 weeks) 9% 7% 0%
Never 56% 52% 100%
The variables shown below are included in the subsequent MANCOVA analyses for 84 patients. Chi-square test for contingency table was used for categorical data and
Kruskal-Wallis test was used for age and BMI. Variables that differed significantly (FDR #0.05) are bolded.
doi:10.1371/journal.pone.0030044.t001
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which were highly correlated with each other, would be linked by
common biological pathways. Ingenuity Pathway Analysis (IPA)
canonical pathways were associated (P,0.01 and at least 4 gene
probes) in 12 of 43 clusters (see Table S3). In addition, direct
inspection of cluster #24 revealed that this cluster included
a number of genes expressed in Paneth cells, such as the a-
defensins.
Permutational based MANCOVA with Stepwise Variable
Selection and Gene Cluster Centroids as Independent
Variables
For 84 of 99 ileal mucosal samples with microarray profiles, 454
pyrosequencing of the V3, V4, and V5 (V3–V5) hypervariable
regions of the 16 S rRNA gene was completed using primers
adopted by the Human Microbiome Project [34], [35]. A vector
consisting of the relative frequencies of six phyla/subphyla
categories (excluding the seventh ‘‘other Taxa’’ category):1.)
Actinobacteria, 2.) Bacteroidetes, 3.) Firmicutes. Clostridium
Group IV, 4.) Firmicutes. Clostridium Group XIVa, 5.)
Firmicutes. Bacilli, 6.) Proteobacteria, was used as the dependent
variables. The 43 microarray cluster medians were used as cluster
centroids [36], [37], in addition to disease phenotype and the
other 12 input variables in the analysis. Using the stepwise variable
selection method, permutation based MANCOVA selected disease
phenotype, a Paneth cell gene enriched cluster, two xenobiotic
metabolism gene enriched clusters, and NOD2 genotype as the
independent variable set (see Table 2). Gene-probes included in
these three clusters are listed in Table 3. We obtained similar
results using the cluster mean or first principle component [36],
[38] as the cluster centroids (data not shown). We also obtained
similar results when parallel Sanger and 454 V1–V3 16 S
sequence datasets were used (data not shown).
To examine correlations between gene transcripts and bacterial
taxa at a more granular level, we selected individual gene
transcripts within these microarray clusters and individual
bacterial genera. The selected transcripts included the alpha
defensins, (DEFA5 and DEFA6), which have exhibited altered
regulation in ileal Crohn’s disease [10], [39], [40], and included
cellular detoxification genes, which have exhibited altered
regulation in ulcerative colitis [41]. The bacteria genera selected
included the Faecalibacterium and Shigella/Escherichia genera,
because the relative frequency of Faecalibacterium prausnizii has been
reported to be reduced and that of Escherichia coli have been
reported to be increased in patients with ileal CD. Bacterial
genera, previously selected as ulcerative colitis related were also
included in this analysis [42].
As shown in Figure 2, a positive correlation (P,0.05) between
the relative frequency of the Faecalibacterium genus (Firmicutes
Phylum, Clostridium GroupIV) and mRNA expression levels of
Paneth cell genes, including DEFA5 and DEFA6, was observed in
ileal CD patients but not in non-IBD controls or UC patients.
Negative correlations (P,0.05) were observed between the relative
frequency of the Bacteroidetes genus and Parabacteroides genus
(Bacteroidetes phylum) and mRNA expression levels of the REG
genes in ileal CD patients, but not in UC or non-IBD control
patients. Furthermore, negative correlations (P,0.05) were
observed between the relative frequency of the Parabacteroides
genus (Bacteroidetes phylum) and mRNA expression levels of
Figure 1. Venn diagram of the union of the gene-probes identified by SAM. Two-class unpaired SAM analyses of ileal CD vs Control
samples, UC vs. Control Samples and ileal CD vs. UC samples have been conducted. The number of gene-probes that overlapped between the three
separate analyses is shown within the Venn diagram. The total numbers of upregulated and downregulated gene-probes for each individual analysis
are shown on the side.
doi:10.1371/journal.pone.0030044.g001
Table 2. Selected variables associated (P#0.05) with shifts in
ileum associated microbial composition.
Selected Variables Df R
2 P value
Phenotype 2 0.0460 0.037
Paneth cell cluster (Cluster 24) 1 0.0576 0.002
Xenobiotic cluster A (Cluster 13) 1 0.0319 0.024
Xenobiotic cluster B (Cluster 2) 1 0.0291 0.041
NOD2 genotype 1 0.0414 0.011
doi:10.1371/journal.pone.0030044.t002
Host Microbial Interactions in IBD
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e30044cellular detoxification genes in non-IBD control and ileal CD
patients but not in UC patients. The highest correlation (out of
.500 comparisons) was observed between Faecalibacterium and
DEFA6 (r=0.59, P=0.00024, FDR=0.057) in ileal CD patients.
Discussion
In this exploratory study, we report the results of the analysis
integrating human ileal mucosal microarray expression profiles
with microbiota profiles. Since the number of genes and bacterial
taxa greatly exceed the number of samples, we sought to shrink
these high dimensional datasets by grouping the bacteria taxa into
broad phyla/subphyla categories, and by selecting potentially
disease relevant transcripts by SAM followed by clustering using 1-
correlation dissimilarity measure. We were gratified to observe
that a number of the resulting clusters could be linked to canonical
pathways by IPA. Furthermore inspection of one of the clusters
revealed that it included a number of genes that were expressed in
Table 3. Gene list for the Paneth cell gene enriched cluster and the xenobiotic metabolism gene enriched clusters A and B.
Cluster Function Gene list
Paneth Cell (cluster 24) ENPP7, DEFA5, TM4SF20, RGN, MDK, REG3A, BCMO1, BAI2, GPR172B, CA9, ANGPTL4, ASAH2, CEL, NPC1L1, SERPINB5, SERPINA1, NPNT, VNN1,
DDO, PRSS2, PLA2G2A, PRSS1, SLC2A12, CCK, CDKN1C, UNC5CL, FBXO2, KLK12, SIGLEC15, CLCA1, RHBG, CCL25, AZGP1, LCT, DEFA6, GCNT1,
SLC16A4, UNC93A, LOC100128979, WNT11, VNN1, PEAR1, LOC643201, ITLN2, REG4, LOC100240735, LOC100240735, REG3G, PRSS2
Xenobiotic Metabolism
Cluster A (cluster 13)
CPO, PRSS7, AATK, HEBP1, ABCG5, CYP2C9, GATM, SLC5A12, GSTA1, MS4A8B, SULT1E1, PTGR1, CYP2C19, CYP2C19, ABCC2, NR0B2, ABCA4,
APOC3, CYBRD1, MME, MTTP, GSTA2, UNC93A, SST, ACE2, GSTA3, SOAT2, FBP1, TM4SF5, SLC23A3, EDN2, NR1I3, PDIA2, ENPEP, UGT2B4,
C17ORF78, SLC5A11, ANO6, KCNH6, C19ORF77, C21ORF129, MGAM, ABCC2, PDZK1, CYP2C18, CPS1, NQO2, DNASE1, DHDH, OSR2, BST1, PIK3C2G,
MEP1B, APOB, RBP2, AADAC, PEPD, MAOB, MAOB, APOA4, REEP6, MEP1A, GSTA5, PHYHIPL, OAT, MEP1A, SULT2A1, MGAT3, MME, GSTA2, TIAM2,
LOC285733, EMB, SLC16A10, SLC6A4, EMB, LOC149703, TMEM229A, C19ORF69
Xenobiotic Metabolism
Cluster B (cluster 2)
NELL2, ACOX2, CYP2J2, SULT1A2, PRR15L, GUCA2A, LGALS2, PCK2, DDC, RNF128, FMO1, FAM82A2, ABAT, SAT2, NAT8, AGXT2, BTNL3, MYO1A,
MTHFS, SMPD3, CBS, VIL1, EDN3, ABCG2, MOSC2, G6PC, CDK20, CYP4F3, VIL1, ABHD6, HSD17B11, TRPM6, C9ORF24, KLKB1, TM4SF4, EFNA1, CBR1,
ANKRD43, SLC9A3R1, SUSD2, SLC1A7, LINCR, CHP2, SLC17A4, MAF, FAM151A, OAZ1, KAZALD1, APOM, C9ORF40, ANXA13, GUCA2B, GLRX,
C6ORF123, EPHX2, CTU2, CES2, PBX1, KAZALD, SP8, SULT1A4, TRPM6, VPS35, NAT8B, CSNK1D, STAU2, PTPRF, PGRMC2, AGPHD1, AGXT2, APOM,
IYD, LRAT, LAMA1, ADI1
The genes selected for further correlation analyses are bolded.
See Table S3 for the complete list of all clusters.
doi:10.1371/journal.pone.0030044.t003
Figure 2. Correlations between selected mRNA transcripts and bacterial genera. Selected transcripts from the Paneth cell and xenobiotic
metabolism microarray clusters are listed with their public reference along the vertical axis (see text). Selected bacterial genera are classified by phyla.
CD, ileal CD phenotype; Control, non-IBD control phenotype; UC, UC phenotype; F, Firmicutes; B, Bacteroidetes; P, Proteobacteria. Red squares
represent positive correlations (P,0.05), and green squares represent negative correlations (P,0.05).
doi:10.1371/journal.pone.0030044.g002
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three microarray clusters for further analysis. These genes
included the alpha defensins and members of the regenerating
gene (REG) family. The alpha defensins are antimicrobial peptides
that are secreted by Paneth cells. Manipulation of alpha defensin
expression in experimental animals has been shown to alter gut
microbial composition [43]. On the other hand, monoassociation
of a Bacteroidetes species with germ free animals was shown to
alter regulation of Paneth cell gene expression [44]. Altered
expression of alpha defensins have been associated with the ileal
Crohn’s disease phenotype. The REG genes belong to the calcium
(C-type) dependent lectin superfamily and have been noted to be
upregulated in CD and UC intestinal tissues [45], [46]. Expression
levels of cellular detoxification genes, which are target genes for
the transcription factor pregnane X receptor (PXR and also
termed NR1I2), have been previously noted to be down-regulated
in the colons of UC patients [41]. The expression levels of these
genes were correlated with bacterial genera that had been
previously reported to be disease associated [42]. At a threshold
of P#0.05, exploratory analyses revealed potential correlations
between transcript levels of specific genes with individual bacterial
genera (e.g. Faecalibacterium, Bacteroidetes and Parabacteroides),
that were modulated by disease phenotype. By honing in on these
promising correlations identified by exploratory studies, we hope
to be able to further confirm these observations in an expanded set
of samples. Co-linearity between input variables may occur,
despite our efforts to shrink the dimensions of the datasets. This
may account for why C. difficile was not selected in this subset of the
microbial dataset. Alternatively C. difficile may not have been
selected because paired microarray and microbial data have been
collected on a smaller number of subjects thus far. While the use of
immunomodulators and anti-TNFa biologics were included as co-
variates in the MANOVA [24], we cannot completely exclude the
potential confounding effects of these drugs on the microbial
composition and mucosal gene expression. Nevertheless our results
demonstrate that integrating paired expression profiles and
microbial data can lead to the discovery of biologically meaningful
host-microbial interactions in inflammatory bowel diseases. We
anticipate that as we expand the sample set, other associations will
be detected.
Materials and Methods
Patients and Acquisition of Macroscopically Disease-
unaffected Proximal Margin Ileal Tissue Samples
This study was approved by the Institutional Review Boards of
Washington University-St. Louis and Stony Brook University. Ileal
CD patients undergoing initial ileocolic resection, UC patients
undergoing initial total colectomy and Control non-IBD patients
undergoing either right hemicolectomy or total colectomy were
prospectively enrolled in a consecutive fashion by the Washington
University Digestive Diseases Research Core Center Tissue
Procurement Facility to donate surgically resected tissue samples
between April 2005 and February 2010. Patients who were
unwilling or unable to give informed consent were excluded.
Clinical information and patient samples were stripped of all
identifying information and assigned a patient code and sample
code. The de-identified patients were genotyped for the three
major NOD2 and ATG16L1 genotypes and phenotyped as
previously described [15]. All of the patients received antibiotics
within one hour of incision. Ex-vivo biopsies were obtained of the
disease unaffected proximal margin of the surgical resection
specimens as previously described. RNA and DNA were extracted
from the biopsy samples as previously described [15].
Human Ileal Mucosal Expression Profiles
The test RNA and a common reference ileal RNA were labeled
and the resulting probes were hybridized to Agilent Whole Human
Genome Arrays (Agilent No. G4410A) as previously described
[15]. The pre-processing, filtering and normalization of the array
data was conducted using the R package LIMMA [47], [48].
Probes with all Genepix flags less than 250 were treated as absent
and removed from the dataset. There were technical duplicates on
three samples and the log2 ratios for these three samples were
averaged prior to analysis. Genes that were differentially expressed
between ileal CD vs. Control, UC vs. Control, and ileal CD vs.
UC were selected by conducting three two-class unpaired
comparisons using SAM, with a cutoff of change .1.5 fold and
false discovery rate (FDR) ,0.05 [29]. The hierarchical clustering
was carried out by using 1-r dissimilarity measurement and Ward
linkage as previously described [32], [34]. The cluster number was
decided based on inspection of the coefficient of determination
(R2) plot [49], [50]. The biological significance of these clusters
was assessed by using Ingenuity Pathway Analysis (IPA) software
[51]. To select cluster-enriched IPA canonical pathways, we
lowered the threshold of the p-value from 0.05 to 0.001, and
included only pathways that included $4 genes in the cluster. The
data discussed in this publication have been deposited in NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE24287 (http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE24287).
Assessment of Ileal-associated Microbial Composition
The V3–V5 region was targeted by using barcoded primers
357F (59-CCTACGGGAGGCAGCAG-39) and 907R
(59CCGTCAATTCMTTTRAGT) and were identical to the
primers used by the Human Microbiome Project to characterize
the microbiota in healthy human subjects. All sequences were
screened for fidelity to a 16 S rRNA bacterial covariance model
(CM) based on secondary structure using the Infernal software
package [52] and were checked for chimerism with ChimeraSlayer
[53] http://microbiomeutil.sourceforge.net/#A_CS). Potentially
chimeric sequences and sequences lacking high fidelity to the CM
were removed from subsequent analysis. Genera level taxonomic
calls were produced by the RDP Classifier [53], which performs
naı ¨ve Bayesian taxonomic classification versus a training set. This
project used the code and training set provided by RDP (Version
2.1, http://sourceforge.net/projects/rdpclassifier/) April 6, 2010
respectively. The sequences were also classified into seven phyla/
subphyla categories. The seven categories were 1) Actinobacteria,2 )
Bacteroidetes,3 )Firmicutes.Clostridium Group IV, 4) Firmicutes.
Clostridium Group XIVa, 5.) Firmicutes. Bacillus, 6.) Proteobacteria,
and 7.) Other taxa. The subdivisions of the Firmicutes phyla were
based on concordance between the RDP classifier and the
Greengenes 16 S rRNA phylogenetic schema [54–56]. The
Clostridium GroupIV and Clostridium Group XIVa taxa are
subsets of the Lachnospiriciae taxon [22], [57]. The sequence
screening, classification, final binning and enumeration operations
described were performed within a python based analysis pipeline
created for this project [24]. Assembled Sanger sequences were
deposited in GenBank accession HQ739096-HQ821395. 454 V1–
V3 and V3–V5 sequences were deposited in the Sequence Read
Archive accession SRX021348-SRX021368, SRX037800-
SRX037802. Clinical and genotyping data can be accessed
through the dbGAP authorized access system. Request access to:
phs000255. The study accession is SRP002479 ‘‘Effect of Crohn’s
disease risk alleles on enteric microbiota’’. In order to request
access to any of the individual-level datasets within the controlled-
access portions of the database, the Principal Investigator (PI) and
Host Microbial Interactions in IBD
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to co-sign a request for data access, which will be reviewed by an
NIH Data Access Committee at the appropriate NIH Institute or
Center (https://dbgap.ncbi.nlm.nih.gov/aa/wga.
cgi?page=login).
Statistical Analysis
In order to investigate the relationship between gene expression
and bacteria composition, permutational MANOVA with stepwise
variable selection was performed for a vector including six bacteria
taxa, which served as the dependent variable [58]. Because the
dependent variable is a vector of compositions, the centered log
ratio transformation was used on the bacterial proportions [59].
The cluster medians [36], [37] were chosen to represent the cluster
centroids and included as input variables along with clinical
information (patients phenotype, age, race, smoking, BMI, gender,
C._difficile, 5-ASA, steroids, immunomodulator, TNF) and geno-
types (NOD2 and ATG16L1).
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